Company intelligence / Profile preview

IOCB Tech

Prague, Czech Republiciocbtech.cz ↗
Ownership
Private
Employees
~25
Development stage
Commercial
01

Overview

IOCB Tech has successfully facilitated the commercialization of numerous scientific discoveries from the Institute of Organic Chemistry and Biochemistry Prague. Its efforts have resulted in more than two dozen license agreements with major pharmaceutical companies for drugs addressing CNS disorders, inflammation, cancer, microbial resistance, and more. Notable successes include contributions to blockbuster drugs like tenofovir for HIV/AIDS treatment. The company continues to expand its translational capabilities with new centers like PharmTheon focused on innovative drug development using advanced modalities including AI.

Therapeutic areas
OncologyImmunologyNeurologyInfectious Diseases
Modalities
Small moleculesPeptidesResearch tools
Industry
Biotech
02

Drug pipeline

3 assets

lipophosphonoxins

Preclinical

2 more assets in the full pipeline.

Request access →
03

Partnerships

Gilead SciencesMerckNovo NordiskSHINE Medical TechnologiesAstraZeneca

Beyond the preview

Go deeper on IOCB Tech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on IOCB Tech.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call